Alzheimer Disease, drug therapy
- Alzheimer Disease, drug therapy
- Accession Number
Drug Drug Description Crenezumab Crenezumab has been used in trials studying the treatment of Alzheimer's Disease. Tricaprylin Tricaprilin has been used in trials studying the supportive care and treatment of Alzheimer's Disease. Donanemab Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody targeted against an epitope at the N-terminal of a specific type of amyloid beta (Aβ) - pyroglutamate Aβ - which is found... Aducanumab A monoclonal antibody indicated in the treatment of Alzheimer's disease. Lecanemab An amyloid beta-targeting antibody used to treat Alzheimer’s Disease in patients with mild cognitive impairment or mild dementia with a known amyloid beta pathology.
- Drugs & Drug Targets
Drug Target Type Aducanumab Amyloid beta A4 protein target Lecanemab Amyloid beta A4 protein target